In 2016 CDC made a $144 million equity investment into ARM Cement, a publicly listed cement business with operations in Kenya, Tanzania and Rwanda. ARM Cement was an investment with high development impact potential. The aim was to support the growth of a regional manufacturer and by so doing reduce the cost and increase the availability of cement across the East African region, creating jobs and spurring infrastructure development.<\/p>
Due to a number of factors, CDC\u2019s investment in ARM was ultimately not successful and the CDC investment has been written off. Write-downs were accounted for in 2016 (December); 2017 (March, June, September, December) and 2018 (June).<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1559", "label" : {"_value" : "Biography information for Sir James Duddridge"} } , "answeringMemberConstituency" : {"_value" : "Rochford and Southend East"} , "answeringMemberPrinted" : {"_value" : "James Duddridge"} , "dateOfAnswer" : {"_value" : "2020-03-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-03-11T17:05:28.277Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "20"} , "answeringDeptShortName" : {"_value" : "International Development"} , "answeringDeptSortName" : {"_value" : "International Development"} , "date" : {"_value" : "2020-03-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "CDC: ARM Cement"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for International Development, how much CDC Group have invested in ARM Cement; how much of that investment has been lost or written down; and on what dates the losses and write-downs were recognised.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4786", "label" : {"_value" : "Biography information for Zarah Sultana"} } , "tablingMemberConstituency" : {"_value" : "Coventry South"} , "tablingMemberPrinted" : [{"_value" : "Zarah Sultana"} ], "uin" : "23631"} , {"_about" : "http://data.parliament.uk/resources/1181959", "AnsweringBody" : [{"_value" : "Department for International Development"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1181959/answer", "answerText" : {"_value" : "
Financial creditors of ARM Cement Limited who were partially or wholly repaid following CDC Group\u2019s investment were: Citibank N.A.; I&M Bank Ltd; Bank of Africa Kenya Ltd; Eastern and Southern African Trade and Development Bank; Development Bank of South Africa; Guaranty Trust Bank Kenya Ltd; Aureos Capital; Chase Bank Ltd; Barclays Bank of Kenya; CfC Stanbic Bank Ltd; Victoria Commercial Bank; Africa Finance Corporation.<\/p>
Information on CDC\u2019s current investment relationships with the above investees, where applicable, are available on its website https://www.cdcgroup.com/en/our-investments/<\/a><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1559", "label" : {"_value" : "Biography information for Sir James Duddridge"}
}
, "answeringMemberConstituency" : {"_value" : "Rochford and Southend East"}
, "answeringMemberPrinted" : {"_value" : "James Duddridge"}
, "dateOfAnswer" : {"_value" : "2020-03-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-03-09T18:09:45.153Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "20"}
, "answeringDeptShortName" : {"_value" : "International Development"}
, "answeringDeptSortName" : {"_value" : "International Development"}
, "date" : {"_value" : "2020-03-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "CDC: ARM Cement"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for International Development, who the ARM Cement creditors are who were partially or wholly repaid following CDC Group\u2019s initial investment in the company; and what CDC Group\u2019s (a) previous and (b) current business or investment relationships are with each of those creditors.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4786", "label" : {"_value" : "Biography information for Zarah Sultana"}
}
, "tablingMemberConstituency" : {"_value" : "Coventry South"}
, "tablingMemberPrinted" : [{"_value" : "Zarah Sultana"}
], "uin" : "23632"}
, {"_about" : "http://data.parliament.uk/resources/1183282", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1183282/answer", "answerText" : {"_value" : " The NHS Long Term Plan, published in January 2019, has committed to accelerate action to improve maternity and neonatal care services and to halve the 2010 rates of stillbirths, neonatal and maternal deaths and brain injuries occurring during or soon after birth by 2025 and to reduce the pre-term birth rate from 8% to 6%.<\/p> Public Health England is undertaking a systematic review and refresh of the Healthy Child Programme in England.<\/p> In 2013, seven cities, including Coventry, were designated \u2018Marmot Cities\u2019 in England and received national expertise and support from the Institute of Health Equity and Public Health England. Of these, Coventry was the only city to renew this commitment in 2016 and continue to use the title.<\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1481", "label" : {"_value" : "Biography information for Ms Nadine Dorries"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Bedfordshire"}
, "answeringMemberPrinted" : {"_value" : "Ms Nadine Dorries"}
, "dateOfAnswer" : {"_value" : "2020-03-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-03-16T16:06:33.487Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2020-03-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Infant Mortality: Coventry"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce infant and child mortality in Coventry.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4786", "label" : {"_value" : "Biography information for Zarah Sultana"}
}
, "tablingMemberConstituency" : {"_value" : "Coventry South"}
, "tablingMemberPrinted" : [{"_value" : "Zarah Sultana"}
], "uin" : "26185"}
, {"_about" : "http://data.parliament.uk/resources/1183283", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1183283/answer", "answerText" : {"_value" : " Future funding for social care will be set out at the next Spending Review. The upcoming Spending Review will consider a broad range of factors that influence the demand for and cost of providing adult social care services.<\/p> Putting social care on a sustainable footing, where everyone is treated with dignity and respect, is one of the biggest challenges we face as a society.<\/p> In 2020/21 we are providing councils with access to an additional £1.5 billion for adults and children\u2019s social care.<\/p> This £1.5 billion is on top of maintaining £2.5 billion of existing social care grants and will support local authorities to meet rising demand and continue to stabilise the social care system.<\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"}
}
, "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"}
, "answeringMemberPrinted" : {"_value" : "Helen Whately"}
, "dateOfAnswer" : {"_value" : "2020-03-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-03-16T11:31:24.313Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2020-03-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Dementia: Social Services"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies on social care funding of dementia care costs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4786", "label" : {"_value" : "Biography information for Zarah Sultana"}
}
, "tablingMemberConstituency" : {"_value" : "Coventry South"}
, "tablingMemberPrinted" : [{"_value" : "Zarah Sultana"}
], "uin" : "26186"}
, {"_about" : "http://data.parliament.uk/resources/1183284", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1183284/answer", "answerText" : {"_value" : " The National Institute for Health and Care Excellence (NICE) has been asked to develop recommendations for the National Health Service on the use of Kuvan for the treatment of phenylketonuria through its technology appraisal programme. NHS commissioners are legally required to fund medicines recommended in NICE technology appraisal guidance.<\/p> NICE\u2019s appraisal had been suspended as the manufacturer of Kuvan, BioMarin, had withdrawn from the process. However, BioMarin has now agreed to re-engage in the appraisal and NICE will now aim to publish guidance on Kuvan as soon as possible. Further information on the appraisal is available on NICE\u2019s website at the following link:<\/p>